With the US and the EU market, the Japanese biotech market is one of the largest and most dynamic market in the world. The 2nd week of October is the golden week for the Biotech industry in Japan. It is indeed the week of Osaka Partnering Event and Bio Japan which can be seen like the 2 main gates of entry for European biotech in Japan with more than 1 400 companies participating to both events, all happening in a week time.
But doing business in Japan can be challenging in many ways. It why the European cluster alliance bioXclusters is glad to invite you to participate to its next webinar focusing on « Doing Business In Japan ».
After useful reminder about Japanese business culture and market, we will focus on biotech business case with successful European biotech on the Japanese market.
Doing Business in Japan :
Biotech shared experiences :
Time of the webinar: 11 May 2023 from 09:00 to 10h30 AM
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026